Sunshine Biopharma moves coronavirus drug candidate into IND studies

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. QGEN
6. LVS
7. LRCX
8. NDAQ
9. BRO
10. BFH

Go back to Sunshine Biopharma moves coronavirus drug candidate into IND studies

Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies

September 16, 2026 9:00 AM EDT

Nanomolar potency against PLpro with broad-spectrum SARS-CoV-2 variants activitySignificant dose-dependent suppression of pulmonary viral replication in vivoStrong oral bioavailability and preferential lung enrichment across multiple species

FORT LAUDERDALE, FL / ACCESS Newswire / September 16, 2026 / Sunshine Biopharma Inc. (NASDAQ: SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medications including drugs in oncology and antivirals, is pleased to announce that it has advanced its lead Coronavirus drug candidate into... More